GlaxoSmithKline (GSK) Consumer Healthcare has appointed Debjit Rudra as General Manager of its south-east Asia operations.
Based in Singapore, Mr Debjit will oversee GSK’s consumer healthcare business across South East Asia, reporting directly to Zubair Ahmed who heads the Asia Middle East Africa region.
He was previously Asia Vice President of Unilever’s Household Care division. He held key positions in sales, marketing and senior regional leadership roles during his 22-year tenure at the company.
Most recently, Mr Debjit assumed the role of Asia Vice President of Unilever’s Household Care division, playing a central role in the development and implementation of Unilever’s strategic roadmap for the category across Asia and ANZ.
Source: Asia Online
Big Pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.
Current methods for diagnosing Alzheimer’s disease rely on a complex combination of self- and caregiver-reported symptoms, a physical examination and either a PET scan or a spinal tap to look for evidence of amyloid plaque build-ups in the brain. But a new artificial intelligence-based method may make the diagnostic process a much more objective one.
There is lots of talk about diversity and inclusion in business, including in pharma and medtech. A new report by the Open Political Economy Network (OPEN), a think tank focusing on migration and diversity, released its “Minority Businesses Matter: Europe” report highlighting the successes and challenges of ethnic minority-owned businesses in Europe.
